Featured

AdvaMedDx Priorities 2021

AdvaMed and AdvaMedDx have prioritized supporting MedTech’s mobilization to the pandemic to protect patients and public health through the development of and advocacy on a wide range of policy matters both administrative and legislative to foster innovation, expand access to testing and to bolster testing infrastructure and capability for future pandemic preparedness.

In Vitro Diagnostic COVID-19 Tests

In vitro diagnostic (IVD) manufacturers have taken key steps to increase patient access to coronavirus diagnostic testing in laboratories, hospitals, and other testing sites across the country to guide patient care and protect public health. Learn which companies have developed IVDs that have received Emergency Use Authorization from the U.S. Food and Drug Administration.

Recent Newsletters


See All

Recent Tweets

April 1, 2021 - 1:59pm
Congrats to our member company, Abbott, for receiving extended EUA for BinaxNOW COVID19 Self Test for… https://t.co/PavF8nwKZI
April 1, 2021 - 12:49pm
Our member company, Quidel, is supplying and with the QuickVue test for the… https://t.co/1UVqu4AkEK
April 1, 2021 - 12:44pm
Our member company, BD Corporation, received EUA for the Veritor Plus System for asymptomatic screenin… https://t.co/hHcmhp0fGe